SCHEMBL7239708

SCHEMBL7239708

CCC(OC(=O)NC)c1nc(C)nc2c1COCN2c1c(C)cc(Cl)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220686 0.93
SCHEMBL7226518 0.90 KDM4E (0.31)
SCHEMBL7225877 0.85
SCHEMBL7219383 0.78
SCHEMBL7220088 0.76 GABRG2 (0.31)
SCHEMBL7225765 0.74 CRHR1 (0.33)
SCHEMBL7228064 0.72 CRHR1 (0.45)
SCHEMBL5599988 0.68 CRHR1 (0.36)
SCHEMBL7227610 0.64 CRHR1 (0.53)
SCHEMBL7220553 0.61 CRHR1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103553-A2 Substituted heterocyclic derivatives Pfizer Products Inc. (US) 2001-05-30 EP claimed
US-6525067-B1 Corticotropin releasing factor antagonists; such as 1-(2-methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl)-propan-1-one-oxime PFIZER INC 2003-02-25 US disclosed
EP-1103553-A2 Substituted heterocyclic derivatives Pfizer Products Inc. (US) 2001-05-30 EP disclosed